Company news

Mid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns

During AAPI Heritage Month in May — and all year long — Medtronic comes together to foster belonging among Asian and allied employees around the world.

The company earns its highest-ever ranking on the prestigious list.

Chairman and CEO Geoff Martha issued a message to 90,000+ global Medtronic employees on the invasion of Ukraine.

The second season will focus on topics that demonstrate how Medtronic is engineering the extraordinary.

Company advanced its pipeline, launched new products, won share, and delivered earnings growth despite COVID-19 impact on healthcare procedure volumes

Fortune ranks Medtronic second within Medical Products and Equipment industry

How Medtronic is removing barriers to opportunity and advancing inclusion, diversity, and equity

Medtronic Diabetes business advances global pediatric strategy

Company continued to launch new products, win share, and deliver strong earnings growth; market procedure volumes impacted by COVID-19 resurgence

Medtronic makes a series of bold moves to strengthen global partnerships and improve patient outcomes in the greater Asia Pacific region

Harnessing the power of bold environmental, social, and governance (ESG) initiatives to drive better outcomes for the world

Announces bold ambition to become the global healthcare technology leader

Medtronic Chairman and CEO Geoff Martha played a pivotal role at the B20 Summit in Italy

Business 20 leaders to make sweeping recommendations to improve global healthcare.

Strong Financial Performance on Continued Procedure Volume Recovery and Share Gains from New Product Launches

As a result, Medtronic receives highest U.S. honor for support of Guard and Reserve employees.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today received U.S. Food and Drug Administration (FDA) 510(K) clearance on the first and only...

Medtronic has analyzed iPhone technology and found that it presents no increased risk of interference with Medtronic implantable cardiac rhythm devices, such as pacemakers, implantable...

Medtronic’s fourth quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in April 2020.

February 23 – Earlier today, Medtronic reported third quarter 2021 financial results. This infographic provides key highlights. For more information, view our press release or visit...

Temporary Limited Modifications to Bio-Medicus Adult Cannulae and Introducers, Bio-Medicus Cannulae Kits, & Bio-Medicus Pediatric Cannulae and Introducers Indications to Support Longer Duration Use in ECMO Therapy to Address COVID-19